China Ranibizumab API Manufacturers Factory Suppliers
-
Semaglutide CAS 910463-68-2 API
Semaglutide, for subcutaneous use, contains semaglutide, is a human GLP-1 receptor agonist (or GLP-1 analog). The main protraction mechanism of semaglutide is albumin binding, facilitated by...
-
Liraglutide CAS 204656-20-2 API
Liraglutide, an analog of human GLP-1 and acts as a GLP-1 receptor agonist, produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae, has been engineered to be...
-
Fulvestrant CAS 129453-61-8 API
Fulvestrant Injection for intramuscular administration is an estrogen receptor antagonist.
The chemical name is 7-alpha-[9-(4,4,5,5,5-penta fluoropentylsulphinyl) nonyl]estra-1,3,5-(10)-... -
Bortezomib CAS 179324-69-7 API
Bortezomib is a modified dipeptidyl boronic acid. The material is provided as a mannitol boronic ester which, in reconstituted form, consists of the mannitol ester in equilibrium with its...
-
Carfilzomib CAS 868540-17-4 API
Carfilzomib is a sterile, white to off-white lyophilized powder and is available as a single-use vial. Carfilzomib is a modified tetrapeptidyl epoxide, isolated as the crystalline free base.
-
Ranibizumab CAS 347396-82-1 API
Ranibizumab injection is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab binds to and inhibits the biologic activity of human...
-
Pemetrexed Disodium CAS 150399-23-8 API
Pemetrexed Disodium for injection, is an antifolate antineoplastic agent that exerts its action by disrupting folate-dependent metabolic processes essential for cell replication. Pemetrexed...
-
Azacitidine is a pyrimidine nucleoside analog of cytidine. Azacitidine is 4-amino-1-β-D-ribofuranosyl-s-triazin-2(1H)-one.The empirical formula is C8H12N4O5. The molecular weight is 244....
WebRanibizumab (Lucentis?; manufactured in the United States by Genentech/Roche) is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth...
WebOct 3, 2022?· prescribed ranibizumab biosimilar 1 THE FIRST AND ONLY FDA-APPROVED BIOSIMILAR INTERCHANGEABLE WITH LUCENTIS ? FOR ALL...
WebSep 20, 2021?· The U.S. Food and Drug Administration today approved Byooviz (ranibizumab-nuna) as the first biosimilar to Lucentis (ranibizumab injection) for the...
WebNo Commissions, No Strings Attached. Get Connected for FREE. View All Manufacturers & Suppliers of Ranibizumab API with Drug Master Files (DMF), CEP/COS, Japanese...
WebRanibizumab is a recombinant humanized monoclonal antibody fragment that binds human vascular endothelial growth factor A (VEGF-A) and suppresses neovascularization....
WebSep 16, 2022?· Ranibizumab-nuna (Byooviz, Samsung Bioepis, South Korea/Biogen, USA) This is the first biosimilar ranibizumab molecule to receive approval by both the FDA...